PERFUSION CHEMOTHERAPY FOR GYNECOLOGICAL MALIGNANCY.
D000230:Adenocarcinoma; D002294:Carcinoma, Squamous Cell; D010478:Chemotherapy, Cancer, Regional Perfusion; D005185:Fallopian Tube Neoplasms; D005260:Female; D006801:Humans; D008466:Mechlorethamine; D008637:Mesenchymoma; D009369:Neoplasms / Q000453:epidemiology* / Q000628:therapy*; D010051:Ovarian Neoplasms; D011379:Prognosis; D013724:Teratoma; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms; D014846:Vulvar Neoplasms
D008466:Mechlorethamine
ADENOCARCINOMA; CARCINOMA, EPIDERMOID; CERVIX NEOPLASMS; FALLOPIAN TUBE NEOPLASMS; ISOLATION PERFUSION; MECHLORETHAMINE; MESENCHYMOMA; NEOPLASM STATISTICS; NEOPLASM THERAPY; OVARIAN NEOPLASMS; PROGNOSIS; TERATOID TUMOR; UTERINE NEOPLASMS; VULVAR NEOPLASMS